期刊文献+

P16与Ki67的表达在子宫颈上皮内瘤变组织学诊断与分级中的临床意义 被引量:10

Clinical significance of P16/Ki67 expression for histological diagnosis and grading of cervical intraepithelial neoplasia
在线阅读 下载PDF
导出
摘要 目的考察P16与Ki67的表达在子宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)组织学诊断与分级中的临床意义。方法针对86例患有宫颈糜烂的育龄期妇女行宫颈组织活检、HE染色常规病理分析及免疫组化SP法检测其P16与Ki67的表达情况。结果 HE染色分析:未见上皮内细胞病变及恶性病变的宫颈组织(NILM)18例(阴性对照组);低级别上皮内瘤变(CINⅠ级)25例,高级别上皮内瘤变(CINⅡ级、CINⅡ~Ⅲ级和CINⅢ级)43例;P16与Ki67免疫组化分析:P16与Ki67在高级别CIN宫颈损伤中的表达明显高于低级别CIN及NILM损伤组织,差异具有统计学意义(P<0.05)。结论 P16与Ki67双阳性标记对于辅助诊断CIN病理分级有益,其可以作为鉴别宫颈癌前病变、指导临床手术治疗及评估预后的生物标识物。 Objective To explore the clinical significance of P16 and Ki67 expression for histological diagnosis and grading of cervical intraepithelial neoplasia (CIN). Methods A total of 86 cases of cervical erosion in the child-bearing period were detected by cervical biopsy, haematoxylin and eosin (HE) staining, and immunohistochemical SP method for P16 and Ki67 expression. Results HE staining in the tissue samples of cervical biopsy showed that there were 18 specimens of intraepithelial lesion or Malignancy ( NILM), 25 speci-mens of low-grade CIN lesions (CIN Ⅰ ) and 43 specimens of high -grade CIN lesions (CIN Ⅱ/CIN Ⅱ - Ⅲ/CINⅢ ). P16 and Ki67 ex-pression was significantly higher in the high-grade CIN lesions than that in the low-grade CIN lesions, non-intraepithelial lesions and ma-lignant lesions of the cervix (NILM) ( P 〈 0.05 ). Conclusions P16 and Ki67 can be helpful to aid objective CIN lesion grading, which are the diagnostic and prognostic utility and guiding treatment of specific biomarkers in identifying true cancerous precursor lesions.
出处 《安徽医药》 CAS 2013年第9期1540-1542,共3页 Anhui Medical and Pharmaceutical Journal
关键词 宫颈上皮内瘤变 免疫组化 P16 KI67 cervical intraepithelial neoplasia immunohistochemistry P16 Ki67
  • 相关文献

参考文献15

  • 1Wentzensen N.Triage of HPV-positive women in cervical cancer screening[J].Lancet Oncol,2013,14(2):107-109.
  • 2Wheeler CM.The natural history of cervical human papillomavirus infections and cervical cancer:gaps in knowledge and future horizons[J].Obstet Gynecol Clin North Am,2013,40(2):165-176.
  • 3Carrigg A,Teschendorf C,Amaro D,et al.Examination of sources of diagnostic error leading to cervical cone biopsies with no evidence of dysplasia[J].Am J Clin Pathol,2013,139(2):422-427.
  • 4Carozzi F,Gillio-Tos A,Confortini M,et al.Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results:a prospective analysis of a nested substudy of the NTCC randomised controlled trial[J].Lancet Oncol,2012,14(2):168-176.
  • 5付军,辛海,华沛.液基薄层细胞学/TBS检测方法、阴道镜及两者联合应用在诊断宫颈癌及其癌前病变中的临床价值[J].中国实验诊断学,2009,13(11):1583-1586. 被引量:6
  • 6孔瑛.TCT取材质量控制对宫颈病变诊断的影响[J].安徽医药,2010,14(9):1047-1048. 被引量:3
  • 7Formentin A,Archambault J,Koushik A,et al.Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix[J].Int J Cancer,2012,132(8):1821-1830.
  • 8田斌,胡敏.宫颈炎患者人乳头状瘤病毒16和18亚型的检测分析[J].安徽医药,2010,14(12):1450-1451. 被引量:7
  • 9Chummun K,Fitzpatrick M,Lenehan P,et al.Diagnostic and therapeutic dilemma associated with atypical glandular cells on liquid-based cervical cytology[J].Cytopathology,2012,23(6):378-382.
  • 10Petry KU,Luyten A,Scherbring S.Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests:results from a primary HPV screening project from 2006 to 2011 in Wolfsburg,Germany[J].Gynecol Oncol,2012,128(2):282-287.

二级参考文献37

共引文献53

同被引文献65

  • 1王桂芝,卢书信,张克政.caspase-3、bcl-2基因及Ki-67在胃癌前病变中的表达及意义[J].中国临床保健杂志,2004,7(3):198-200. 被引量:2
  • 2李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 3邹先进,蔡兰,刘颖,王梅,谢军花.子宫颈癌前病变与子宫颈癌组织中p16^(INK4A)蛋白检测及其与人乳头状瘤病毒感染的关系[J].中华妇产科杂志,2004,39(9):625-626. 被引量:25
  • 4Sari AF, Safaei A, Pourjabali M, et al. Evaluation of Ki67, p16 and CK17 markers in differentiating cervical intraepi- thelial neoplasia and benign lesions[J]. Iran J Med Sci, 2013,38(1) . 15-21.
  • 5Koc N,Sahin D,Ayas S. Reevaluation of negative cone bi- opsy results after a positive cervical biopsy finding[J]. J Low Genit Tract Dis,2013,17(2):154-159.
  • 6Liu AN, Sun P, Liu JN. Clinicopathologic characteristics and prognostic factors in patients with operable HER-2 overexpressing breast cancer [ J ]. Asian Pac J Cancer Prey,2012,13 (4) : 1197-1201.
  • 7Norherg T, Klanr S, Karl G, et al. Increased p53 mutation frequency during tumor progress, results from a breast cancer cohort [ J ]. Cancer Ros, 2001,61 (22) : 8317- 8321.
  • 8Gnant M, Harbeck N, Thomssen C. St. Gallen2011 : sum- mary of the consensus discussion [ J ]. Breast Care ( Ba- sel) ,2011,6 : 136-141.
  • 9Marty M, Cognetti F, Maranichi D, et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxelin patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 Study Group [ J ]. J Clin Oncol, 2005,23 ( 19 ) : 4265-4274.
  • 10Milde-Langosch K, Kam T, Muller V, et al. Validity of pro- liferation markers KI-67 ,TOP2A ,and RacGAP1 in molec- ular subgroups of breast cancer [ J ]. Breast Cancer Res Treat,2013,137 ( 1 ) :57-67.

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部